SCHEMBL22719925

SCHEMBL22719925

CCCNC(=O)c1ncc(COCc2ccc(OC)cc2)c(CO)c1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGLN2 Q96KS0 3/20 0.41
EGLN1 Q9GZT9 6/20 0.41
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
SMN1; SMN2 Q16637 6/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
TP53 P04637 1/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.38
NFKB1 P19838 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22719898 0.89 EGLN1 (0.39) EGLN2EGLN1NPC1RAB9AKDM4E
SCHEMBL2219007 0.89 SMPD1 (0.44) EGLN2EGLN1HDAC3HDAC1HDAC2
SCHEMBL22719957 0.88 SMN1; SMN2 (0.42) EGLN2EGLN1HDAC3HDAC1HDAC2
SCHEMBL12444335 0.85 HTT (0.40) EGLN1HDAC6SMN1; SMN2NPC1RAB9A
SCHEMBL13577624 0.83 EGLN1 (0.40) EGLN1HDAC6SMN1; SMN2NPC1RAB9A
SCHEMBL1503184 0.82 MAOB (0.44) EGLN1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL1503272 0.82 NPC1 (0.52) EGLN1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL22719946 0.81 GAA (0.44) EGLN2HDAC3HDAC1HDAC2HDAC6
SCHEMBL22738236 0.81 EGLN1 (0.39) EGLN2EGLN1NPC1RAB9AALDH1A1
SCHEMBL22283911 0.79 NPC1 (0.39) SMN1; SMN2NPC1RAB9ATP53KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020237374-A1 PICOLINIC ACID DERIVATIVES AND USE THEREOF FOR TREATING DISEASES ASSOCIATED WITH ELEVATED CHOLESTEROL MONTREAL HEART INSTITUTE (CA) 2020-12-03 WO disclosed
WO-2020237374-A1 PICOLINIC ACID DERIVATIVES AND USE THEREOF FOR TREATING DISEASES ASSOCIATED WITH ELEVATED CHOLESTEROL MONTREAL HEART INSTITUTE (CA) 2020-12-03 WO disclosed